At a dedication today of the new Jeffrey Leiden Center for Cell and Genetic Therapies in Boston’s Seaport, Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) announced plans to build another 344,000 square foot facility in the Seaport to support the company’s continued rapid growth, in particular the expansion of .
-New 344,000 square foot cell and genetic therapies research and manufacturing facility to be built-
-Facility to support continued R&D growth-
. | May 17, 2022